ASH2014
Loading viewer...
report
Format: PDF report
This report discusses the clinical activity of Indatuximab Ravtansine (BT062) combined with Lenalidomide in treating relapsed multiple myeloma patients.
Loading viewer...
report
Format: PDF report
This report discusses the clinical activity of Indatuximab Ravtansine (BT062) combined with Lenalidomide in treating relapsed multiple myeloma patients.
presentation
report
First Eagle Investment Management
report
Equity Residential
report
Bio-Rad Laboratories
report
PT Bank Maybank Indonesia Tbk
